Drance, S. M.
May 1961
Angiology;May1961, Vol. 12 Issue 5, p149
Academic Journal
Focuses on the efficacy of antifibrinolytic agent fibrinolysin in the treatment of central retinal artery occlusion. Dissolution of intravascular clots occurring as a result of trauma; Developments observed in a patient injected with large doses of the drug followed by anticoagulant therapy; Adverse reactions involved in the utilization of fibrinolysin.


Related Articles

  • Ethinylestradiol/drospirenone.  // Reactions Weekly;8/25/2007, Issue 1166, p11 

    The article describes the case of an 18-year-old girl who developed retinal central artery occlusion while receiving an ethinylestradiol/drospirenone combined oral contraceptive. Eleven days after receiving the oral contraceptive, the girl reported vague abdominal and left-arm pain, and...

  • Bupivacaine/hyaluronidase/lidocaine.  // Reactions Weekly;4/26/2008, Issue 1199, p15 

    The article describes the case of a 79-year-old woman who developed retinal arterial occlusion following administration of a Sub-Tenon's block containing bupivacaine, hyaluronidase and licodaine for cataract surgery. The patient experienced arterial occlusion as manifested in blurred vision,...

  • THROMBOLYSIS WITH FIBRINOLYSIN IN CEREBRAL ARTERIAL OCCLUSION. Sussman, Bernard J.; Fitch, Thomas S. P. // Angiology;May1961, Vol. 12 Issue 5, p169 

    Eleven patients with angiographically demonstrated cerebral or carotid occlusions were treated with fibrinolysin. Evidence of vascular clearing was obtained in 5 patients. Partial results were noted in 2 cases. The authors favor intracarotid administration of the enzyme. Clinical evaluation...

  • THROMBOLYTIC THERAPY. Loewe, Leo; Halpern, Alfred // Angiology;May1961, Vol. 12 Issue 5, p147 

    Discusses the fibrinolytic treatment of thromboembolic disease. Potential of fibrinolysin, a fibrinolytic agent to dissolve thrombi within the circulation; Capacity to dissolve the fibrin binding the clot without affecting the other proteins in the blood producing adverse reactions; Influence of...

  • FIBRINOLYSIN THERAPY IN THROMBOEMBOLIC DISEASE. Randolph, W. Alan; Starling, Howard M. // Angiology;May1961, Vol. 12 Issue 5, p179 

    Reports on the aid of fibrinolysin therapy in thromboembolic disease. Toxicity of the agent as indicated by the relatively small number of toxic responses; Indication of a negative hemorrhagic complications caused by the drug; Demonstration of drug efficacy in the drug.

  • To Study The Relationship Between The Axial Length of The Eye Ball and the Retinal Vein Occlusion. Gupta, Rashmi Chander; Mengi, R. K. // JK Science;Oct-Dec2010, Vol. 12 Issue 4, p180 

    The study was conducted on 50 patients attending the Eye OPDs of Ophthalmology Department of Government Medical College Jammu during the year. 25 patients were clinically diagnosed to have Retinal Vein Occlusion and were compared with 25 age and sex matched controls. The axial lengths of both...

  • The predictive value of retinal vascular findings for carotid artery atherosclerosis: are further recommendations with regard to carotid atherosclerosis screening needed? Song, Yeo-Jeong; Cho, Kyoung-Im; Kim, Seong-Man; Jang, Hyun-Duk; Park, Jung-Min; Kim, Sang-Soo; Kim, Dong-Jun; Lee, Hyeon-Gook; Kim, Tae-Ik // Heart & Vessels;May2013, Vol. 28 Issue 3, p369 

    Vascular retinopathy is the consequence of vascular disease, and the retina is the only place where the arteries can be visualized directly. The purpose of this study was to evaluate the predictive value of retinal vascular findings for carotid artery atherosclerosis. From December 2009 to...

  • BOX 11-7 DISSOLVING CLOTS. Scanlon, Valerie C.; Sanders, Tina // Essentials of Anatomy & Physiology;Jan2007, p268 

    Information on dissolving clots from Chapter 11 of the book "Essentials of Anatomy & Physiology" is presented. It identifies arteries, vessels and veins that might be affected by abnormal blood clots. It offers information on streptokinase, a bacterial toxin used to dissolve blood clots, and its...

  • Synergy of in vitro Thrombolytic Action of Combinations of Recombinant Staphylokinase and Single-Chain Urokinase-Type Plasminogen Activator. Aisina, R. B.; Moukhametova, L. I.; Varfolomeyev, S. D. // Biochemistry (00062979);Nov2003, Vol. 68 Issue 11, p1252 

    Kinetics of lysis of human plasma clots immersed in plasma were studied in vitro at 37°C under the influence of recombinant staphylokinase, single-chain urokinase-type plasminogen activator (scu-PA), and their simultaneous and consecutive combinations. Staphylokinase and scu-PA caused...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics